Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Taro Pharmaceutical Industries Ltd. (TARO)

72.3721   -0.578 (-0.79%) 02-21 09:47
Open: 72.62 Pre. Close: 72.95
High: 72.3721 Low: 72.37
Volume: 1,365 Market Cap: 2747M
Taro Pharmaceutical Industries Ltd is a science-based pharmaceutical company. It develops, manufacture and market Rx and OTC (over-the-counter) pharmaceutical products primarily in the United States, Canada and Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 73.704 - 74.053 74.053 - 74.381
Low: 71.14 - 71.544 71.544 - 71.925
Close: 72.291 - 72.922 72.922 - 73.514

Technical analysis

as of: 2020-02-20 4:44:08 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 94.84     One year: 101.45
Support: Support1: 72.04    Support2: 59.94
Resistance: Resistance1: 81.20    Resistance2: 86.86
Pivot: 75.79
Moving Average: MA(5): 72.83     MA(20): 77.63
MA(100): 83.13     MA(250): 88.89
MACD: MACD(12,26): -3.52     Signal(9): -3.30
Stochastic oscillator: %K(14,3): 6.82     %D(3): 6.20
RSI: RSI(14): 19.63
52-week: High: 109.42  Low: 72.04  Change(%): -28.3
Average Vol(K): 3-Month: 6395  10-Days: 4325

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TARO has closed above bottom band by 25.8%. Bollinger Bands are 12.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 16 Feb 2020 15:00:00 +0000
Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/16/2020

Sun, 19 Jan 2020 15:00:00 +0000
Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 1/19/2020

Tue, 14 Jan 2020 13:19:49 +0000
PJP's Underlying Holdings Could Mean 14% Gain Potential

Fri, 15 Nov 2019 18:38:48 +0000
Health Care Sector Update for 11/15/2019: TARO,AMRN,TORC

Fri, 15 Nov 2019 20:46:56 +0000
Health Care Sector Update for 11/15/2019: PSTV,TARO,AMRN,TORC

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 38.54
Shares Float (M) 8.82
% Held by Insiders 77.10
% Held by Institutions 11.44
Shares Short (K) 206
Shares Short P. Month (K)

Stock Financials

EPS 7.090
Book Value (p.s.) 52.560
PEG Ratio -0.87
Profit Margin 38.24
Operating Margin 40.77
Return on Assets (ttm) 7.6
Return on Equity (ttm) 12.7
Qtrly Rev. Growth -16.3
Gross Profit (p.s.) 11.565
Sales Per Share
EBITDA (p.s.) 7.417
Qtrly Earnings Growth -27.60
Operating Cash Flow (M) 280.59
Levered Free Cash Flow (M) 153.41

Stock Valuations

P/E 10.29
P/E Growth Ratio 0.01
P/BV 1.39
P/S 4.32
P/CF 10.02

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-12-27
Ex-Dividend Date 2018-12-09
Forward Dividend
Last Split Date
Last Split Ratio 2
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.